Related Experiment Video
Updated: Jun 6, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Construction and Validation of a Predictive Model for Long-Term Major Adverse Cardiovascular Events in Patients with
Peng Yang1, Jieying Duan2,3, Mingxuan Li2,3
1Department of Geriatric Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
Insights
A new scoring system accurately predicts major adverse cardiovascular events (MACE) in acute myocardial infarction (AMI) patients. This tool improves risk stratification, outperforming existing methods like the GRACE score for better patient outcomes.
Area of Science:
- Cardiology
- Medical Statistics
- Clinical Prediction Models
Background:
- Existing scoring systems for major adverse cardiovascular events (MACE) in acute myocardial infarction (AMI) have limitations.
- There is a need for improved predictive tools to guide patient management and outcomes.
Purpose of the Study:
- To develop and validate a novel scoring system for predicting 3-year MACE in patients with AMI.
- To enhance the accuracy of risk stratification for AMI patients.
Main Methods:
- A nomogram-based scoring system was developed using data from 461 AMI patients (369 training, 92 validation).
- Independent risk factors were identified through logistic regression.
- Model performance was evaluated using calibration curves, decision curve analysis, ROC curves, and survival analysis.
Main Results:
- The nomogram incorporated seven variables: age, diabetes, prior MI, Killip class, CKD, Lp(a), and PCI.
- The scoring system demonstrated good predictive ability with an AUC of 0.775 (training) and 0.789 (validation).
- The new system showed superior predictive performance compared to the GRACE risk score (AUC 0.776 vs 0.731).
Conclusions:
- The developed nomogram-based scoring system is effective for predicting MACE in AMI patients.
- This tool offers improved risk stratification capabilities for clinical decision-making.
Purpose:
Current scoring systems used to predict major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI) lack some key components and their predictive ability needs improvement. This study aimed to develop a more effective scoring system for predicting 3-year MACE in patients with AMI.
Patients And Methods:
Our statistical analyses included data for 461 patients with AMI. Eighty percent of patients (n=369) were randomly assigned to the training set and the remaining patients (n=92) to the validation set. Independent risk factors for MACE were identified in univariate and multifactorial logistic regression analyses. A nomogram was used to create the scoring system, the predictive ability of which was assessed using calibration curve, decision curve analysis, receiver-operating characteristic curve, and survival analysis.
Results:
The nomogram model included the following seven variables: age, diabetes, prior myocardial infarction, Killip class, chronic kidney disease, lipoprotein(a), and percutaneous coronary intervention during hospitalization. The predicted and observed values for the nomogram model were in good agreement based on the calibration curves. Decision curve analysis showed that the clinical nomogram model had good predictive ability. The area under the curve (AUC) for the scoring system was 0.775 (95% confidence interval [CI] 0.728-0.823) in the training set and 0.789 (95% CI 0.693-0.886) in the validation set. Risk stratification based on the scoring system found that the risk of MACE was 4.51-fold higher (95% CI 3.24-6.28) in the high-risk group than in the low-risk group. Notably, this scoring system demonstrated better predictive ability than the GRACE risk score (AUC 0.776 vs 0.731; P=0.007).
Conclusion:
The scoring system developed from the nomogram in this study showed favorable performance in prediction of MACE and risk stratification of patients with AMI.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT